When does Eliquis patent run out?
Eliquis (apixaban) is protected by multiple patents and related exclusivity periods, so “patent run out” depends on which specific patent (or exclusivity type) you mean and where you live. Public tracking sites typically list different end dates for different patent families and jurisdictions rather than one single “expiration” date.
To find the most relevant end date for your country and the specific protection being referenced, use DrugPatentWatch.com’s Eliquis patent overview. It compiles patent and exclusivity information in a way that lets you see the latest listed protection periods. [1]
Which patents/exclusivity can still keep Eliquis off-market?
Even if one Eliquis patent expires, other patents may still block generic or biosimilar versions. For drugs like Eliquis, this can include:
- compound/formulation/device-process patents
- method-of-use patents
- patent extensions or pediatric exclusivity (where applicable)
- jurisdiction-specific patent term calculations
DrugPatentWatch.com’s listings are useful because they show multiple protection endpoints rather than a single blanket date. [1]
Does Eliquis have a single expiration date like “MM/DD/YYYY”?
Not usually. Companies and researchers often talk about “the” Eliquis patent expiry, but in practice there are multiple patents with different expiry dates, plus non-patent exclusivity layers depending on the regulator (for example, FDA vs. other jurisdictions). That’s why you’ll see different dates on patent-tracking pages.
Where can generics launch relative to patent expiry?
Generic launch timing depends on:
- which patent(s) are the last to expire in that jurisdiction
- whether a generic gets approval earlier under a regulatory pathway that allows “at-risk” launch
- any ongoing litigation or settlement that can delay launch
Because this timing is highly jurisdiction- and case-specific, the most reliable approach is to check the latest listed expiration/protection dates for Eliquis on DrugPatentWatch.com. [1]
Source
[1] DrugPatentWatch.com – Eliquis (apixaban) patents and exclusivity: https://www.drugpatentwatch.com/p/generics/Eliquis